Article

Bbarrons.com on 2020-01-15 13:43

Nektar Stock Plunges 15% as FDA Panel Rejects Opioid Painkiller

Nektar Therapeutics stock plunged 15% in premarket trading on Wednesday, as the biotech company scrapped its opioid painkiller after it was rejected ...

San Francisco

Daina Graybosch

Related news

MNektar stock drops more than 10% as FDA advisers say no to painkiller marketwatch.com
BNektar Therapeutics Stock Plunges Because There’s No Shortage of Bad News barrons.com
Fyé , Stock Island
FDA OKs opioid painkiller for teens bangordailynews.com
United States
'Unlikeable' opioid from Nektar faces FDA pain point bizjournals.com
Amid nationwide opioid crisis, SF health providers reduce painkiller prescriptions SF Examiner
Americas , Northern California , San Francisco
FDA asks drugmaker to remove opioid painkiller from the market Washington Post
Great Malvern , Dublin , Indiana , Tennessee , Washington
Amid opioid concerns, FDA approves Peninsula company's powerful painkiller bizjournals.com
FDA OKs powerful opioid pill as alternative to IV painkiller abqjournal.com
Seattle , Redwood City , Americas , Raeford
FDA Asks Endo to Pull “Risky” Opioid Painkiller From Market phillymag.com
FDA seeks removal of opioid painkiller from the market Denver Post
Indiana , Tennessee
AFDA asks drugmaker to stop selling its opioid painkiller apnewsarchive.com
Great Malvern , Philadelphia , Ireland , Dublin , Indiana
EFDA approves opioid painkiller 1,000 times stronger than morphine eu.usatoday.com
Massachusetts